| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/10/2008 | WO2008081581A1 Foxp3 peptide vaccine |
| 07/10/2008 | WO2008081568A1 Novel macrolide compound |
| 07/10/2008 | WO2008081537A1 Aromatic amino acid derivative with lat1 inhibitory activity, lat1 inhibitor containing the same and method for producing the same |
| 07/10/2008 | WO2008081035A1 Anti-tumor vaccine derived from normal chemically modified cells |
| 07/10/2008 | WO2008080968A1 Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature |
| 07/10/2008 | WO2008080938A1 Use 2-substituted pyridines for cancer treatment |
| 07/10/2008 | WO2008080937A1 2-substituted pyrimidines i in therapy |
| 07/10/2008 | WO2008080623A2 Neutralization of cd95 activity blocks invasion of glioblastoma cells in vivo |
| 07/10/2008 | WO2008080455A1 Tetrahydrobenzoisoxazole - and tetrahydroindazole derivatives as modulators of the mitotic motor protein |
| 07/10/2008 | WO2008080369A1 Steady liposomal composition |
| 07/10/2008 | WO2008080367A1 Liposome formulation and process for preparation thereof |
| 07/10/2008 | WO2008080291A1 Poly(glutamic acid)-drug conjugate with an amino acid as a linker |
| 07/10/2008 | WO2008080223A1 Compositions and methods for treating hyperproliferative disease |
| 07/10/2008 | WO2008056266A3 Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a]pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido[1,2-a]pyrimidin-6-one derivatives |
| 07/10/2008 | WO2008052798A3 Fgfr4 promotes cancer cell resistance in response to chemotherapeutic drugs |
| 07/10/2008 | WO2008051805A3 Triazolo-pyridazine protein kinase modulators |
| 07/10/2008 | WO2008030625A3 Antibodies against human melanoma-associated chondroitin sulphate proteoglycan (mcsp) |
| 07/10/2008 | WO2008029294A3 Method of producing anthracycline derivatives |
| 07/10/2008 | WO2008024301A3 Bis(thiohydrazide amides) for use in preventing or delaying the recurrence of melanoma |
| 07/10/2008 | WO2008021038A3 Pyridobenzazepine compounds and methods for inhibiting mitotic progression |
| 07/10/2008 | WO2008019376A3 Compositions and methods using anti-cs1 antibodies to treat multiple myeloma |
| 07/10/2008 | WO2008011603A3 Modulating notch1 signaling pathway for treating neuroendocrine tumors |
| 07/10/2008 | WO2004083365A9 Compounds and their use for specific and simultaneous inhibition of genes involved in diseases and related drugs |
| 07/10/2008 | WO2002102229A9 Diagnosing tumorigenicity and determining resistance to anticancer therapy |
| 07/10/2008 | WO2002072778A3 Method for identifying inhibitors of g protein coupled receptor signaling |
| 07/10/2008 | US20080167444 Abc Transporter Inhibitor |
| 07/10/2008 | US20080167382 Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases |
| 07/10/2008 | US20080167369 Semisynthesis Process for the Preparation of 10-Deacytyl-N-Debenzoyl-Paclitaxel |
| 07/10/2008 | US20080167368 4-{4-[3-(2-fluoro-5-trifluoromethylphenyl)ureido]phenyl}-1H-pyrrole-3-carboxamide; anticarcinogenic agents; FAK, KDR and Tie2 kinase inhibitors |
| 07/10/2008 | US20080167362 Time-release tablets or capsules also containing an opoid or analgesic; cyclooxygenase-2 inhibitors |
| 07/10/2008 | US20080167352 3-(4-Chloro-phenyl)-adamantane-1-carboxylic acidisopropylamide; antiproliferative, antiinflammatory agent, angiogenesis inhibitor; sphingolipid-derived signaling pathway; coupling acid or acylhalide of phenyl-adamantane derivatives with aminoalkyl-pyridine |
| 07/10/2008 | US20080167345 Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors |
| 07/10/2008 | US20080167338 Compounds and methods for kinase modulation, and indications therefor |
| 07/10/2008 | US20080167334 Modulators of estrogen receptor alpha/beta G protein-coupled receptor 30, e.g., 1-(4-(6-Bromo-benzo[1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl)1-ethanone; treating diseases such as cancer, neurodegenerative disorders, obesity, osteoporosis, and symptoms of menopause |
| 07/10/2008 | US20080167330 Anticancer agents |
| 07/10/2008 | US20080167328 Antitumor agents |
| 07/10/2008 | US20080167327 Crystalline, formed by crystallizing from an aqueous solution without agitation; treating cancer |
| 07/10/2008 | US20080167314 Condensed Imidazole Compound And Use Thereof |
| 07/10/2008 | US20080167293 Pyrrolobenzodiazepines |
| 07/10/2008 | US20080167289 Pyrimidinohydrodiazepinones, e.g., 2-(1,6-dihydro-4-methyl-6-oxopyridin-3-ylamino)-9-cyclopentyl-8,9-dihydro-5,7,7-trimethyl-5H-pyrimido[4,5-b][1,4]diazepin-6(7H)-one; especially c-Met kinase inhibitors; anticancer agents |
| 07/10/2008 | US20080167288 Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases |
| 07/10/2008 | US20080167287 Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| 07/10/2008 | US20080167279 Multiple daily dosages containing at least 0.50 mg of levonorgestrel and an estrogen component, e.g., norgestimate, with less than 30 mcg EE equivalent; oral contraceptives and hormone replacement therapy |
| 07/10/2008 | US20080167274 Multiphasic hormonal regimen wherein at least one of the daily dosages has at least 0.5 mg of norgestrel and an estrogen component; prevent cancers such as epithelial ovarian cancer by inhibiting the conversion of normal and dysplastic ovarian epithelial cells to neoplastic cells |
| 07/10/2008 | US20080167272 Thalidomide metabolites and methods of use |
| 07/10/2008 | US20080167271 Pharmaceutical compositions comprising a bisphosphonate compound |
| 07/10/2008 | US20080167264 Materials and methods to inhibit hodgkin and reed sternberg cell growth |
| 07/10/2008 | US20080167257 Therapy of acroparaesthsia, allergic (psoric) conditions, allergic reactions, alopecia, amnesia, anaphrodisia, angina, arthritis, asthenopia, biliary sycosis, burns, cancerous conditions, such as colon cancer, malignant melanoma and malignant nasal polyps, carpal tunnel syndrome, colds, conjunctivitis |
| 07/10/2008 | US20080167256 Double-stranded RNA (siRNA) capable of suppressing expression of Skp-2 gene; small cell lung cancer |
| 07/10/2008 | US20080167254 Triterpenes derivatives and uses thereof as antitumor agents or anti-inflammatory agents |
| 07/10/2008 | US20080167252 Method for Treating a Patient Undergoing Chemotherapy |
| 07/10/2008 | US20080167251 Angiotensin-(1-7) and Angiotensin-(1-7) Agonists for Inhibition of Cancer Cell Growth |
| 07/10/2008 | US20080167250 Method For Induction and Enhancement of Apoptosis In Tumor Cells |
| 07/10/2008 | US20080167247 modulator of PKC V5 isozyme-specific peptide, or a modification, derivation, fragment, combination, or hybrid thereof; treatment of pain, cancer |
| 07/10/2008 | US20080167244 Use of il-28 and il-29 to treat cancer and autoimmune disorders |
| 07/10/2008 | US20080167241 Mu-1, member of the cytokine receptor family |
| 07/10/2008 | US20080167240 Albumin Fusion Proteins |
| 07/10/2008 | US20080167239 Albumin Fusion Proteins |
| 07/10/2008 | US20080167227 biodrug laminin protein as angiogenesis inhibitors, antitumor agents; Inducing apoptosis in tissues; binding antibodies |
| 07/10/2008 | US20080167221 Heterocarpine, a plant-derived protein with anti-cancer properties |
| 07/10/2008 | US20080167220 Methods for selectively inhibiting janus tyrosine kinase 3 (jak3) |
| 07/10/2008 | US20080166800 Method and medicament for inhibiting the expression of a given gene |
| 07/10/2008 | US20080166797 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 07/10/2008 | US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof |
| 07/10/2008 | US20080166730 Therapeutic and diagnostic proteins comprising a SOCS box |
| 07/10/2008 | US20080166724 VEGF-Modulated Genes and Methods Employing Them |
| 07/10/2008 | US20080166709 MARKs as Modifiers of the p53 Pathway and Methods of Use |
| 07/10/2008 | US20080166432 Biotherapeutics for Mitigation of Health Disorders from Terminalia Arjuna |
| 07/10/2008 | US20080166429 Antitumor agents; cytotoxic toward cells in vivo, in vitro |
| 07/10/2008 | US20080166427 Method for Reducing Gastrointestinal Toxicity Due to the Administration of Tegafur |
| 07/10/2008 | US20080166425 Suppressing cellular cyclin D1 overexpression; mantle cell lymphoma; activating glycogen synthase kinase 3 beta and I kappa B kinase phosphorylation and ubiquitination for proteasome degradation |
| 07/10/2008 | US20080166402 Medical Compositions for Intravesical Treatment of Bladder Cancer |
| 07/10/2008 | US20080166387 Anti-angiogenic compositions and methods of use |
| 07/10/2008 | US20080166378 Death receptor sensitizing compounds and methods of use therefor |
| 07/10/2008 | US20080166375 Activation of Recombinant Diphtheria Toxin Fusion Proteins by Specific Proteases Highly Expressed on the Surface of Tumor Cells |
| 07/10/2008 | US20080166374 Formulating an anti-cancer vaccine comprising an agent that can stimulate an immune response against IL-13R alpha 2 outside of the subject, and administering the vaccine to the subject |
| 07/10/2008 | US20080166369 Cholesterol, pullulan and/or mannan, estrogen receptor mixture which binds to Toll-like receptor and stimulates antitumor response from antigen presenting cell; antiproliferative agents; tissue targeted therapy |
| 07/10/2008 | US20080166366 Intracellular Delivery Vehicles |
| 07/10/2008 | US20080166364 Conjugated to antibody; thrombospondin receptor targeting |
| 07/10/2008 | US20080166363 Improved targetting |
| 07/10/2008 | US20080166359 Anticancer agents; mitogen-activated protein kinases (MEK) |
| 07/10/2008 | US20080166358 Quinazoline derivatives and methods of treatment |
| 07/10/2008 | US20080166355 Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon |
| 07/10/2008 | US20080166354 Using monoclonal antibody specific to inhibitor of protease or of a non-proteolytic matrix-degrading enzyme (IPNME) as therapeutic tool in treatment of cell proliferative disorders |
| 07/10/2008 | US20080166353 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders |
| 07/10/2008 | US20080166351 Kit comprising beacizumab and antitumor agents for use in treatment of metastatic colorectal cancer in a human |
| 07/10/2008 | US20080166350 Nucleotide sequences coding tumor associated antigens for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/10/2008 | US20080166346 Freeze dried monoclonal antibody specific for endothelial growth factor receptors for use treatment of cell proliferative disorders; enhanced storage stability |
| 07/10/2008 | US20080166345 Medicaments comprising gene recombinant antibody against ganglioside gd3 |
| 07/10/2008 | US20080166344 Coadministration of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazol-3-ium bromide and carboplatin; kits |
| 07/10/2008 | US20080166342 Major histocompatibility complex specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, liver and kidney disorders |
| 07/10/2008 | US20080166341 Cripto blocking antibodies and uses thereof |
| 07/10/2008 | US20080166326 Using tumor cells to induce targeted destruction by lymphocytes; tissue directed therapy |
| 07/10/2008 | US20080166301 Therapy for hormone sensitive diseases; side effect reduction; anticancer agents; osteoporosis; endometriosis; benign prostatic hyperplasia; cardiovascular disorders; acne |
| 07/10/2008 | US20080166295 Administering an antibody that selectively binds to the extracellular region of human magic roundabout (MR); inhibiting angiogenesis |
| 07/10/2008 | DE102007022161A1 neue Cyclohexenonverbindungen aus Antrodia camphorata und deren Anwendung cyclohexenone from Antrodia camphorata new and their application |
| 07/10/2008 | DE102007001370A1 RNA-kodierte Antikörper RNA-encoded antibody |
| 07/10/2008 | CA2674365A1 Foxp3 peptide vaccine |
| 07/10/2008 | CA2674084A1 Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy |
| 07/10/2008 | CA2673974A1 Composition and methods for modulating a kinase cascade |